Oxford Gene Technology (OGT) has released the latest addition to its range of CytoSure™ ISCA microarrays for reliable and standardized genomic aberration detection. The new patent pending CytoSure ...
Phase I/II study of idarubicin (Ida), high-dose ara-C, and sorafenib (S) in patients (pts) younger than 65 years with acute myeloid leukemia (AML) ...
A phase I, open-label, dose-escalation study to evaluate the safety, pharmacokinetics, and pharmacodynamics of oral azacitidine in subjects with myelodysplastic syndromes (MDS) or acute myelogenous ...
Agilent Technologies Inc. has introduced the SurePrint G3 Human CGH+SNP microarray platform, a system for simultaneous analysis of chromosomal copy number changes and copy-neutral aberrations. The ...
SALT LAKE CITY--(BUSINESS WIRE)-- ARUP Laboratories, a leading national clinical and anatomic pathology reference laboratory and a leader in innovative laboratory research and development, is pleased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results